1,4-dihydropyridine has been researched along with Head and Neck Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Curti, C; Garcia, CB; Goto, RN; Leopoldino, AM; Lopes, NP; Marín-Prida, J; Ochoa-Rodríguez, E; Pardo-Andreu, GL; Sobral, LM; Sousa, LO; Verdecia-Reyes, Y | 1 |
1 other study(ies) available for 1,4-dihydropyridine and Head and Neck Neoplasms
Article | Year |
---|---|
Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Gene Expression Regulation, Neoplastic; Genes, myc; Head and Neck Neoplasms; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondrial Size; Neoplasm Invasiveness; Neovascularization, Pathologic; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2018 |